Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
- PMID: 37592150
- PMCID: PMC10579170
- DOI: 10.1007/s00198-023-06887-4
Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
Erratum for
-
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.Osteoporos Int. 2023 Nov;34(11):1961-1973. doi: 10.1007/s00198-023-06863-y. Epub 2023 Jul 26. Osteoporos Int. 2023. PMID: 37493978 Free PMC article.
